Showing results 1 to 7 of 7
A novel imidazopyridine PI3K inhibitor with anticancer activity in non-small cell lung cancer cells Lee, Hyunseung; Kim, Soo Jung; Jung, Kyung Hee; Son, Mi Kwon; Yan, Hong Hua; Hong, Sungwoo; Hong, Soon-Sun, ONCOLOGY REPORTS, v.30, no.2, pp.863 - 869, 2013-08 |
Anticancer activity of HS-527, a novel inhibitor targeting PI3-kinase in human pancreatic cancer cells Ryu, Ye-Lim; Jung, Kyung Hee; Son, Mi Kwon; Yan, Hong Hua; Kim, Soo Jung; Shin, Sang Hye; Hong, Sungwoo; et al, CANCER LETTERS, v.353, no.1, pp.68 - 77, 2014-10 |
Development and Biological Evaluation of Potent and Selective c-KITD816V Inhibitors Lee, So Young; Lee, Hyunseung; Kim, Jin Hee; Lee, Suhyun; Kim, Soo Jung; Choi, Byong-Seok; Hong, Soon-Sun; et al, JOURNAL OF MEDICINAL CHEMISTRY, v.57, no.15, pp.6428 - 6443, 2014-08 |
HS-173 as a novel inducer of RIP3-dependent necroptosis in lung cancer Park, Jung Hee; Jung, Kyung Hee; Kim, Soo Jung; Yoon, Young-Chan; Yan, Hong Hua; Fang, Zhenghuan; Lee, Ji Eun; et al, CANCER LETTERS, v.444, pp.94 - 104, 2019-01 |
HS-173, a novel PI3K inhibitor suppresses EMT and metastasis in pancreatic cancer Rumman, Marufa; Jung, Kyung Hee; Fang, Zhenghuan; Yan, Hong Hua; Son, Mi Kwon; Kim, Soo Jung; Kim, Juyoung; et al, ONCOTARGET, v.7, no.47, pp.78029 - 78047, 2016-11 |
HS-438, a new inhibitor of Imatinib-resistant BCR-ABL T315I mutation in chronic myeloid leukemia Yun, Sun-Mi; Jung, Kyung Hee; Kim, Soo Jung; Fang, Zhenghuan; Son, Mi Kwon; Yan, Hong Hua; Lee, Hyunseung; et al, CANCER LETTERS, v.348, no.1-2, pp.50 - 60, 2014-06 |
HS-543 induces apoptosis of Imatinib-resistant chronic myelogenous leukemia with T315I mutation![]() Kim, Soo Jung; Jung, Kyung Hee; Yan, Hong Hua; Son, Mi Kwon; Fang, Z; Ryu, Ye-Lim; Lee, Hyunseung; et al, ONCOTARGET, v.6, no.3, pp.1507 - 1518, 2015-01 |
Discover